Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumors: initial dosimetry and safety results of the P-PRRT trial

被引：0
|
作者：
Del Prete, Michela [1 ,2 ,3 ,4 ]
Buteau, Francois-Alexandre [1 ,2 ,3 ,4 ]
Beaulieu, Alexis [1 ,2 ,3 ,4 ]
Beauregard, Jean-Mathieu [1 ,2 ,3 ,4 ]
机构：
[1] Univ Laval, Dept Radiol & Nucl Med, Quebec City, PQ, Canada
[2] Univ Laval, Canc Res Ctr, Quebec City, PQ, Canada
[3] Univ Laval, Dept Med Imaging, Div Nucl Med, CHU Quabec, Quebec City, PQ, Canada
[4] Univ Laval, Res Ctr, Oncol Branch, CHU Quabec, Quebec City, PQ, Canada
来源：
JOURNAL OF NUCLEAR MEDICINE | 2017年 / 58卷
基金：
加拿大健康研究院;
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
242
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Peptide receptor radionuclide therapy of neuroendocrine tumours with 177Lu-octreotate: first experience in a French Canadian centre
    Del Prete, M.
    Buteau, F. A.
    Beauregard, J. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S725 - S725
  • [22] Delayed Haematological Toxicity in Patients Treated with 177Lu-octreotate Peptide Receptor Radiotherapy (PRRT) for Metastatic Neuroendocrine Tumors (NETs)
    Hentic, O.
    Lebtahi, R.
    Kwekkeboom, D. J.
    Fenaux, P.
    Palazzo, M.
    Boudabous, H.
    Benreguiga, M.
    Rebours, V.
    Maire, F.
    Hammel, P.
    Ruszniewski, P.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 282 - 283
  • [23] Long-term survival and toxicity in patients with neuroendocrine tumors treated with 177Lu-octreotate peptide radionuclide therapy
    Ransom, D.
    Kennedy, K.
    Turner, J.
    Macdonald, W.
    Boardman, G.
    Claringbold, P.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 205 - 205
  • [24] Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours
    Samer Ezziddin
    Feras Khalaf
    Maria Vanezi
    Torjan Haslerud
    Karin Mayer
    Abdullah Al Zreiqat
    Winfried Willinek
    Hans-Jürgen Biersack
    Amir Sabet
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 925 - 933
  • [25] Salvage therapy with 177Lu-octreotate in patients with gastroenteropancreatic neuroendocrine tumors
    Van Essen, Martijn
    Krenning, Eric
    Kam, Boen
    Kwekkeboom, Dik
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [26] Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas
    Iliuta, Ioan-Andrei
    Beauregard, Jean-Mathieu
    Couture, Felix
    Douville, Pierre
    Mac-Way, Fabrice
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (09) : E448 - E450
  • [27] Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours
    Ezziddin, Samer
    Khalaf, Feras
    Vanezi, Maria
    Haslerud, Torjan
    Mayer, Karin
    Al Zreiqat, Abdullah
    Willinek, Winfried
    Biersack, Hans-Juergen
    Sabet, Amir
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (05) : 925 - 933
  • [28] Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTA Octreotate for Somatostatin Receptor-expressing Neuroendocrine Tumors: The First US Experience
    Delpassand, Ebrahim S.
    Samarghandi, Amin
    Zamanian, Sara
    Erion, Jack
    Somone, Jim
    Wolfangel, Robert
    Wolin, Edward M.
    Espenan, Gregory D.
    PANCREAS, 2013, 42 (02) : 373 - 373
  • [29] Long-Term Hematotoxicity After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
    Sabet, Amir
    Ezziddin, Khaled
    Pape, Ulrich-Frank
    Ahmadzadehfar, Hojjat
    Mayer, Karin
    Poeppel, Thorsten
    Guhlke, Stefan
    Biersack, Hans-Juergen
    Ezziddin, Samer
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (11) : 1857 - 1861
  • [30] The technologist role in 177Lu dosimetry for PRRT (Peptide Receptor Radionuclide Therapy)
    Leoni, E.
    Filice, A.
    Palmieri, A.
    Ghiraldini, G.
    Fioroni, F.
    Grassi, E.
    Cola, S.
    Versari, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S850 - S851
12345